The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

13 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Identification of a novel benzimidazole derivative as a highly potent NPY Y5 receptor antagonist with an anti-obesity profile.EBI
Shionogi
Identification of a novel and orally available benzimidazole derivative as an NPY Y5 receptor antagonist with in vivo efficacy.EBI
Shionogi
Design, synthesis and identification of novel benzimidazole derivatives as highly potent NPY Y5 receptor antagonists with attractive in vitro ADME profiles.EBI
Shionogi
Hit to lead SAR study on benzoxazole derivatives for an NPY Y5 antagonist.EBI
Shionogi
Design, synthesis and evaluation of a novel cyclohexanamine class of neuropeptide Y Y1 receptor antagonists.EBI
Tsukuba Research Institute
Aryl urea derivatives of spiropiperidines as NPY Y5 receptor antagonists.EBI
Tsukuba Research Institute
Isomeric thiazole derivatives as ligands for the neuropeptide Y5 receptor.EBI
F. Hoffmann-La Roche
Novel and potent NPY5 receptor antagonists derived from virtual screening and iterative parallel chemistry design.EBI
F. Hoffmann-La Roche
Highly Selective YEBI
Leipzig University
Design of YEBI
TBA
Stereoselective inhibition of butyrylcholinesterase by enantiomers of exo- and endo-2-norbornyl-N-n-butylcarbamates.BDB
Chung Shan Medical University Hospital